Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist is a research paper published in Cancer Immunology Immunotherapy (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: TL1 TR002375
National Institutes of Health
Grant: TR002373
National Institutes of Health
Grant: P50 DE026787
National Center for Advancing Translational Sciences
Grant: UL1TR000427
NCI NIH HHS
Grant: P30 CA014520
NCI NIH HHS
Grant: U01 CA233102
NCATS NIH HHS
Grant: UL1 TR002373
NIH HHS
Grant: DP5 OD024576
NCI NIH HHS
Grant: P50 CA278595
NIGMS NIH HHS
Grant: T32 GM140935
National Institutes of Health
Grant: 5U01CA233102-04
Immunomodulation of the Tumor Microenvironment with Molecular Targeted Radiotherapy to Facilitate an Adaptive Anti-Tumor Immune Response to Combined Modality Immunotherapies
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5TL1TR002375-04
NRSA Training Core
National Institutes of Health
Grant: 5P50DE026787-02
Head and Neck Cancer SPORE at the University of Wisconsin
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Institutes of Health
Grant: 1R35CA197078-01
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
National Institutes of Health
Grant: 5P01CA250972-02
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
National Institutes of Health
Grant: 5T32GM140935-02
Integrated Training For Physician-Scientists
National Institutes of Health
Grant: 5UL1TR000427-08
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 2UL1TR002373-06
University of Wisconsin Institute for Clinical and Translational Research
National Institutes of Health
Grant: 5DP5OD024576-02
Combining Radiation and Tumor-specific AntIbody Therapies to Elicit in Situ Tumor Vaccination
Crawdaddy Foundation
Midwest Athletes Against Childhood Cancer
University of Wisconsin Carbone Cancer Center
St. Baldrick's Foundation
Stand Up 2 Cancer
FWCI
0.82
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 1 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy
Additional file 2 of Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy